Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), bought 30,000 shares at $5.65 ($169K) on 2019-12-03, disclosed to the SEC on 2019-12-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.55 | 10,000 | $56K | 32.9% |
| 2 | $5.65 | 20,000 | $113K | 67.1% |
| Total | $5.62 avg | 30,000 | $169K | 100% |
| Filing → |
| PTGX | SELL | 2026-03-25 | $5.5M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $4.1M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |